BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND MKL1, BSAC, 57591, ENSG00000196588, Q969V6, MRTF-A
5 results:

  • 1. Genomic landscapes of ovarian clear cell carcinoma from latin countries reveal aberrations linked to survival and progression.
    Batista MP; Roffé M; Romero I; López-Guerrero JA; Illueca C; Lopez R; Balieiro Anastácio da Costa AA; De Brot L; Molina JP; Barboza L; Peria FM; Chaud F; Gouvêa Yamada AS; Poveda A; Rego EM
    BMC Cancer; 2023 Jul; 23(1):613. PubMed ID: 37400764
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. mkl1 overexpression predicts poor prognosis in patients with papillary thyroid cancer and promotes nodal metastasis.
    Cheng X; Xu S; Pan J; Zheng J; Wang X; Yu H; Bao J; Xu Y; Guan H; Zhang L
    J Cell Sci; 2019 Aug; 132(16):. PubMed ID: 31363007
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. mkl1 links epigenetic activation of MMP2 to ovarian cancer cell migration and invasion.
    Xu W; Xu H; Fang M; Wu X; Xu Y
    Biochem Biophys Res Commun; 2017 Jun; 487(3):500-508. PubMed ID: 28385531
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The mrtf-a/B function as oncogenes in pancreatic cancer.
    Song Z; Liu Z; Sun J; Sun FL; Li CZ; Sun JZ; Xu LY
    Oncol Rep; 2016 Jan; 35(1):127-38. PubMed ID: 26498848
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Ovarian cancer-derived lysophosphatidic acid stimulates secretion of VEGF and stromal cell-derived factor-1 alpha from human mesenchymal stem cells.
    Jeon ES; Heo SC; Lee IH; Choi YJ; Park JH; Choi KU; Park DY; Suh DS; Yoon MS; Kim JH
    Exp Mol Med; 2010 Apr; 42(4):280-93. PubMed ID: 20177148
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.